This study aims to compare the efficacy against myxomatosis, and the serological response against RHDV2 produced by the simultaneous administration of MIXOHIPRA-H and YURVAC RHD vaccines for rabbits
Results suggest that the simultaneous administration of MIXOHIPRA®-H and YURVAC RHD does not interfere with its efficacy against myxomatosis and the ability to produce antibodies against RHDV2.
The simultaneous administration of these vaccines makes it possible to offer alternatives to current vaccination plans for rabbits.
兔出血病新型變異株RHDV-2不活化疫苗, 注射用乳劑
兔出血病新型變異株RHDV-2不活化疫苗, 注射用乳劑
兔粘液瘤病異源性佐劑活毒疫苗, 注射用冷凍乾燥凍晶
兔粘液瘤病同源性活毒疫苗, 注射用冷凍乾燥凍晶
出血病不活化疫苗, 注射用乳劑
Flunixin meglumine 注射液
維生素 A、D3 和 E 注射液
HIPRA 大學為專業人士提供策略領域的高品質訓練計劃
使用具有最高舒適度和可靠性的進階診斷服務
